Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer
Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer
Simeng Wen,Yundong He,4 Authors,Haojie Huang
2020 · DOI: 10.1038/s41388-020-01456-z
Oncogene · 34 Citations
TLDR
It is demonstrated that aberrantly activated SE upregulates CHPT1 expression and confers Enz resistance in CRPC, suggesting that SE-mediated expression of downstream effectors such asCHPT1 can be viable targets to overcome EnZ resistance in PCa.
